<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: ValiRx loss on the back of cancer treatment development	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/valirx-loss-on-the-back-of-cancer-treatment-development/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/valirx-loss-on-the-back-of-cancer-treatment-development/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Mon, 07 Sep 2020 11:26:09 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: ValiRx shares climb 12% as placings revenues rise and costs fall - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/valirx-loss-on-the-back-of-cancer-treatment-development/#comment-15867</link>

		<dc:creator><![CDATA[ValiRx shares climb 12% as placings revenues rise and costs fall - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 07 Sep 2020 11:26:09 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=19932#comment-15867</guid>

					<description><![CDATA[[&#8230;] and life sciences company ValiRx plc (AIM:VAL) saw its shares bounce on Monday morning, as the company booked a rise in placings [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] and life sciences company ValiRx plc (AIM:VAL) saw its shares bounce on Monday morning, as the company booked a rise in placings [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Curetis finds a salve for its losses as revenues hike 35% - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/valirx-loss-on-the-back-of-cancer-treatment-development/#comment-11713</link>

		<dc:creator><![CDATA[Curetis finds a salve for its losses as revenues hike 35% - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 18 Sep 2019 13:31:50 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=19932#comment-11713</guid>

					<description><![CDATA[[&#8230;] Elsewhere in health and medical news, there have been updates from; Integumen PLC (LON: SKIN), Medica Group PLC (LON: MGP), EMIS Group (LON: EMIS), OptiBiotix Health PLC (LON: OPTI)  NMC Health (LON: NMC), Astrazeneca plc (LON: AZN) and ValiRx Plc (LON:VAL). [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Elsewhere in health and medical news, there have been updates from; Integumen PLC (LON: SKIN), Medica Group PLC (LON: MGP), EMIS Group (LON: EMIS), OptiBiotix Health PLC (LON: OPTI)  NMC Health (LON: NMC), Astrazeneca plc (LON: AZN) and ValiRx Plc (LON:VAL). [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Medica Group dips despite healthy financial performance - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/valirx-loss-on-the-back-of-cancer-treatment-development/#comment-11575</link>

		<dc:creator><![CDATA[Medica Group dips despite healthy financial performance - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 09 Sep 2019 13:37:47 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=19932#comment-11575</guid>

					<description><![CDATA[[&#8230;] Elsewhere in health and medical news, there have been updates from; EMIS Group (LON: EMIS), OptiBiotix Health PLC(LON: OPTI)  NMC Health (LON: NMC), Astrazeneca plc (LON: AZN) and ValiRx Plc (LON:VAL). [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Elsewhere in health and medical news, there have been updates from; EMIS Group (LON: EMIS), OptiBiotix Health PLC(LON: OPTI)  NMC Health (LON: NMC), Astrazeneca plc (LON: AZN) and ValiRx Plc (LON:VAL). [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
